Cargando…
Axillary Adenopathy Secondary to SARS-CoV-2 Vaccination: a Case Report
SARS-CoV-2 mRNA vaccines are safe and effective for the prevention of COVID-19 infection, though local reactions are commonly reported. Axillary lymphadenopathy has also been reported, which has the potential of causing diagnostic confusion and unnecessary testing and procedures. A 58-year-old femal...
Autores principales: | Koff, Alan, Inaty, Hanine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857527/ https://www.ncbi.nlm.nih.gov/pubmed/35224447 http://dx.doi.org/10.1007/s42399-022-01143-y |
Ejemplares similares
-
Unilateral axillary Adenopathy in the setting of COVID-19 vaccine
por: Mehta, Nishi, et al.
Publicado: (2021) -
Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination
por: Robinson, Kristin A., et al.
Publicado: (2021) -
Ipsilateral Axillary Adenopathy from mRNA COVID-19 Vaccines
por: Teo, Shyh Poh
Publicado: (2021) -
Unilateral axillary adenopathy in the setting of COVID-19 vaccine: Follow-up
por: Mehta, Nishi, et al.
Publicado: (2021) -
Breast Cancer Screening and Axillary Adenopathy in the Era of
COVID-19 Vaccination
por: Wolfson, Stacey, et al.
Publicado: (2022)